Patient Safety Priorities

  • #1 Culture of Safety
  • #2 Teamwork
  • #3 Clinical Deterioration
  • #4 Non-Operating Room Anesthesia
  • #5 Perioperative Brain Health
  • #6 Opioid-Related Harm
  • #7 Medication Safety
  • #8 Infectious Diseases
  • #9 Clinician Safety
  • #10 Airway Management
    • APSF Patient Safety Priorities > #7 Medication Safety

    Medication Safety

    Medication safety
    Chair(s): Elizabeth Rebello, MD
    Contributors: Cristy L. Berg, CTSM; Tricia Meyer, PharmD; Brad Taicher, DO, MBA; Tim Vanderveen, PharmD; Tim Dunne, BS; Jevon Oliver, PharmD; Amanda Esposito, CAA; Russell McAllister, MD; Rodrigo Daly-Guris, MD; Rachel Wang, MD; Paul Lefebvre, JD; Gwen Volpe, RPh, LSSBB, FASHP; Allison Doney, MHA; Lauren Partyka, MD; Jennifer Stever, CAA; Max B. Kelz, MD, PhD; Taizoon Dhoon, MD; Edward (Ed) A. Maratea, Jr., MD; Amy Pearson, MD; Alan Merry, MD; Karen Nanji, MD; Travis Lawler, PharmD, MBA; Cindy West, DNP, MBA, CRNA
    1. Drug effects
    2. Labeling issues
    3. Shortages
    4. Technology issues (e.g., barcoding, RFID)
    5. Processes for avoiding and detecting errors

    APSF Activities:

    • The 2018 APSF Stoelting Conference was dedicated to this topic
    • APSF presented panels at the 2019 ASA and New York State Society of Anesthesiologists’ annual meetings
    • Multiple APSF Newsletter articles have been published on this issue in 2020
    • APSF will co-host a summit in 2021 with the Institute for Safe Medication Practices